Home › Bipolar Disorder › Texas
Bipolar Disorder clinical trials in Texas
15 studies for Bipolar Disorder are looking for participants at sites in Texas.
Cities in Texas
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Revival Research Institute, LLC, McKinney
- Pillar Clinical Research - Richardson, Richardson
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT07286175Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Texas Research Group, Coppell
- PsyMed Solutions, Fort Worth
- Kaleidoscope Clinical Research, Houston
- and 3 more
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 3, 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- The University of Texas at Austin, Austin
- REX Clinical Trials LLC, Beaumont
- Kaleidoscope Clinical Research, Houston
- and 1 more
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Nov 3, 2026 · NCT06372964A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Community Clinical Research, Austin
- Adams Clinical Dallas, DeSoto
- Elevate Clinical Research-Houston, Houston
- and 2 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Nov 3, 2026 · NCT07140913A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Community Clinical Research - Cross Park Drive /ID# 272940, Austin
- Elixia - Houston /ID# 279200, Houston
- Mind Matters Psychiatry /ID# 273536, Missouri City
- and 2 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 14, 2026 · NCT06696755Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
- The University of Texas Health Science Center at Houston, Houston
RecruitingPhase 2
Ages 25 to 70 · All sexes · Updated Aug 12, 2026 · NCT06706232Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, DeSoto
RecruitingPhase 1
Ages 10 to 17 · All sexes · Updated Aug 11, 2026 · NCT05025605FOCUS Bipolar: Families Opening Conversations for Understanding Signs
- UT Southwestern Medical Center, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 7 and older · All sexes · Updated Jun 3, 2026 · NCT07622927Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
- The University of Texas Health Science Center at Houston, Houston
Recruiting
Ages 18 to 50 · All sexes · Updated Feb 18, 2026 · NCT05240352Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
- Baylor College of Medicine, Houston
Recruiting
Ages 22 to 64 · All sexes · Updated Jan 26, 2026 · NCT06599099Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study
- University of Texas at Austin, Austin
RecruitingHealthy volunteers welcome
Ages 21 to 26 · All sexes · Updated Jan 12, 2026 · NCT05838274Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)
- The University of Texas Health Science Center at Houston, Houston
Recruiting
Ages 22 to 85 · All sexes · Updated Dec 3, 2025 · NCT04080778Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
- The University of Texas Health Science Center at Houston, Houston
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 22, 2025 · NCT03522545From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.